Company intelligence / Profile preview

Suzhou Strategy Biotechnology

Suzhou, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Suzhou Strategy Biotechnology is a China-based biotechnology company focused on drug discovery and development services. The company leverages high-throughput screening and advanced chemical synthesis platforms to support the development of small molecule and peptide-based therapeutics. Strategy Biotechnology operates primarily as a contract research organization (CRO) and technology incubator, providing specialized R&D services to pharmaceutical partners. Its core expertise lies in lead optimization, medicinal chemistry, and the development of novel drug delivery systems.

Modalities: Small moleculePeptidesBiologic
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Suzhou Strategy Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Strategy Biotechnology.

Explore the full profile